• Polyp Follow-Up Protocols: Refining Surveillance Strategies Post-Screening
  Folasade P. May, MD, PhD, MPhil
  Outline data regarding polyp surveillance intervals focusing on polyp number, size, and histology (SSAs), and identify those with higher familial CRC burden for genetic evaluation.
• Updates on Dysplasia Detection and Surveillance in IBD and PSC-IBD
  Nayantara Coelho-Prabhu, MD, FACG
  Review updated surveillance intervals and methods in patients with IBD and PSC-IBD, focusing on targeted vs random biopsies and the role of chromoendoscopy.
• Tips and Tricks to Visualize and Resect Polyps
  Aasma Shaukat, MD, MPH, FACG
  Review and illustrate methods to visualize and resect polyps, including advanced endoscopic tools and EMR.
• Optimizing Bowel Prep Quality for Colonoscopy
  Brian C. Jacobson, MD, MPH, FACG
  Examine the ACG/US Multi-Society Task Force on Colorectal Cancer guidelines on bowel prep quality for colonoscopy.
• Panel Q & A

• It’s Sticking and Burning and My Testing Is Negative—What Am I To Do?
  John E. Pandolfino, MD, MSCI, FACG
  Identify the most efficient ways to diagnose, test, and treat functional esophageal disorders.
• Is It IBS-C/D, CIC, FD? Making Sense Out of Alphabet Soup
  Anthony J. Lembo, MD, FACG
  Identify the most efficient ways to diagnose, differentiate, test, and treat bowel disorders.
• Pain at the End of the Drain: Why Can’t Anything Be Found?
  Leila Neshatian, MD, MSc
  Evaluate specific causes and treatments for anorectal pain when hemorrhoids, fissures, and fistulas have been ruled out (e.g., proctalgia fugax, levator ani syndrome, chronic proctalgia) and when there may be cause for concern.
• What’s Causing My RUQ Pain: Functional Gallbladder and Sphincter of Oddi Disorders
  Amy E. Hosmer, MD
  Review current classification strategies for non-stone-based gallbladder and sphincter of Oddi disorders and define which cases require GI or surgical interventions.
• Panel Q & A

Saturday Optional Learning Luncheon Bonus Sessions

1. Chronic Diarrhea: A Practical and Efficient Diagnostic Strategy
   Brooks D. Cash, MD, FACG
   Define chronic diarrhea, common and rare causes, and propose an appropriate diagnostic strategy based on clues in patients’ histories.
2. Top Ten CardioGI Tips You Should Use NOW
   Neena S. Abraham, MD, MSc (Epid), MACG
   Apply best practices for managing anticoagulation in the actively bleeding patient.
3. What’s the Deal With Cold, Wet, Hot, and Dry EMR?
   Mohammad Bilal, MD, FACG
   Review data and tips and tricks for different EMR approaches and how to manage lesions.
4. It Just Won’t Go Down: Updates on Dysphagia
   Marcelo F. Vela, MD, MSCR, FACG
   Describe different causes of dysphagia, advantages/disadvantages of esophageal manometry vs FLIP, and current treatment protocols.
5. Is There an Alien Growing in My Belly? Demystifying Abdominal Bloating and Distention
   Brian E. Lacy, MD, PhD, FACG
   Address the differences between bloating and distention (including abdominophrenic dyssynergia) and discuss appropriate diagnostic and treatment strategies.
6. Pouchitis vs Crohn’s: Making the Call, Managing the Consequences
   Edward L. Barnes, MD, MPH, FACG
   Review how to distinguish pouchitis from Crohn’s-like disease of the pouch, and how treatment approaches may differ.
7. Perianal Problems: Gastroenterologists Can Treat These Too!
   Jill K. Deutsch, MD
   Discuss how to differentiate and treat hemorrhoids, fissures, fistula, anal condyloma, and other common perianal complications.
8. Oh No!! I Think That’s the Liver: Best Endoscopic Strategies for Colon Perforations
   Douglas G. Adler, MD, FACG
   Define best practices for the closure of endoscopic perforations and subsequent follow-up.
9. Roles and Goals of Bariatric Endoscopy: Will GLP-1 Agonists Render These Interventions Obsolete?
   Pichamol Jirapinyo, MD, MPH, FACG
   Describe the current role of endobariatrics in treating obesity and how these interventions can and should be utilized in the era of GLP-1 agonists.
10. The Role of Neuromodulation in Treating GI Illness
    Gregory S. Sayuk, MD, MPH
    Define the role of neuromodulation (TCAs, SSRIs, SNRIs, alpha-2 delta ligands, atypical antipsychotics) in treating gastrointestinal disorders and the safety and benefits of using multiple therapies.
11. Complementary and Alternative Medicine in GI: Is This Ready for Prime Time?
    Andrea S. Shin, MD, MSCR
    Assess the evidence on the use of CAM therapies for GI disorders.
12. Updates on the Diagnosis and Management of Hepatic Encephalopathy
    Jasmohan S. Bajaj, MD, MS, FACG
    Describe the current guidelines for the diagnosis and management of hepatic encephalopathy.

Symposium A: Churning and Burning: What’s Up in My Stomach? [LIVESTREAM]
Moderator: Linda Anh B. Nguyen, MD, FACG

• Guideline Recommendations for Functional Dyspepsia and Gastroparesis, or a Lack Thereof
  Linda Anh B. Nguyen, MD, FACG
  Address current guideline “recommendations” for the treatment of functional dyspepsia and gastroparesis and identify what can be done to further develop therapies which may achieve FDA approval in the future.
• Triple Therapy for H. pylori Must Be Eradicated: It’s That Simple
  Shailja C. Shah, MD, MPH
  Explain the treatment of H. pylori and the rationale for removing triple therapy from our armamentarium.
• Is the Gastric Emptying Study Obsolete? New and Innovative Therapies for Assessing Gastric Function
  Joy J. Liu, MD
  Discuss the limitations of 2- and 4-hour gastric emptying studies and the role of this test in an era of wireless motility capsules, breath tests, and peristaltic patches.
• Panel Q & A

Symposium B: Pain in the Pancreas: Assessments of Common Condition
Moderator: B. Joseph Elmunzer, MD, MSc

• Biliary Strictures and Stones: What, When, How?
  B. Joseph Elmunzer, MD, MSc
  Review the latest indications and techniques for treating common biliary obstructions.
• A Practical Approach to Acute Pancreatitis
  Timothy B. Gardner, MD, MS, FACG
  Summarize ACG pancreatitis guidelines, with a focus on early medical management, nutritional strategies, and indications for endoscopic vs surgical management of associated complications (pseudocysts, necrosis, etc.).
• Chronic Pancreatitis: Is This Just Acute Recurrent Pancreatitis or Something More?
  Allison L. Yang, MD, MPH
  Define the underlying causes of chronic pancreatitis, mitigation strategies to reduce development, and best practice treatments for pain relief once it develops.
• Panel Q & A

Symposium C: Feeling More Than Just the Burn: Esophageal Enigmas [LIVESTREAM]
Moderator: Rena H. Yadlapati, MD, MSHS, FACG

• The Burning Question of Acid vs Non-Acid Reflux: How to Differentiate and Treat
  Rena H. Yadlapati, MD, MSHS, FACG
  Describe current diagnostic strategies differentiating acid from non-acid reflux and how to appropriately treat these conditions.
• Eosinophilic Esophagitis: No Longer a Hard Pill to Swallow
  Evan S. Dellon, MD, MPH, FACG
  Explain the criteria used to differentiate EoE from acid reflux, the importance of the EREFS score, and current treatment algorithms for EoE.
• Reflux Redefined: Regurgitation, Rumination, Eructation, and Abelchia
  C. Prakash Gyawali, MD, MRCP, FACG
  Define and differentiate these disorders commonly labeled as “reflux” and apply appropriate diagnostic and treatment strategies.
• Panel Q & A

Symposium D: What’s New in Poo: Lumps, Bumps, and Inflammatory Stumps
Moderator: Darren M. Brenner, MD, FACG

• Chronic Constipation Beyond Laxatives: What to Do When You Still Cannot Poo
  Darren M. Brenner, MD, FACG
  Discuss alternative strategies for treating constipation when OTC and prescription laxatives fail.
• GI Polyposis: Making Sense of Complex Hereditary Disorders
  Jennifer M. Weiss, MD, MS
  Discuss the different types of hereditary colon cancer syndromes (FAP, Lynch syndrome, etc.) and current surveillance recommendations.
• IBD With IBS-Like Symptoms: What’s in a Name?
  Lin Chang, MD, FACG
  Explain the overlapping nature of IBS and IBD, based on joint Rome Foundation and IOIBD consensus recommendations.
• Panel Q & A